Delivery Order 36C25023D0030-36C25024N0279
- Not listed
- This is a delivery order contract awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation for reagents and consumables for the VENTANA medical diagnostic product line. The contract has a ceiling value of $392,455.91 and a period of performance through December 31, 2024. The contract is a firm-fixed-price delivery order, meaning Roche will provide the VA with a set quantity of reagents and...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostic products. The $71,983.60 firm fixed-price contract is for the supply of Roche Diagnostic brand reagents and consumables supplies, with a period of performance through March 21, 2025. The contract has no set-aside designation. Roche Diagnostics has been awarded...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a component of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $126,829.78, is for the provision of Roche testing supplies. It is not designated as a set-aside contract. The contract is part of a...
- This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a network of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation. The contract is for the provision of microbiology reagents, with a base period ending on September 30, 2025 and a ceiling value of $247,544.56. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. Roche Diagnostics Corporation is a leading manufacturer and distributor of...
- This federal contract award was issued by the Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $232,171.83 Firm Fixed Price delivery order contract is for the provision of reagents, with a period of performance ending on September 30, 2026. The contract was awarded on October 1, 2025 and does not have a set-aside designation,...
- This $222,918.10 firm fixed-price delivery order contract was awarded by the Veterans Integrated Service Network 10 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagents and supplies, with a period of performance through January 31, 2026. Roche Diagnostics holds several indefinite delivery contracts and...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is for the provision of in vitro diagnostic reagents and is not set aside for any specific business type. The potential value of the contract is $280,954.91 and the period of performance runs from October 1, 2017 through September 30, 2018. Roche Diagnostics is a foreign-owned,...
- This $297,244.05 firm fixed price delivery order contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is for in vitro diagnostic reagents and supplies, and is not set-aside. Roche Diagnostics has previously held multiple General Services Administration (GSA) Schedule contracts and Indefinite...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation for the procurement of in vitro diagnostic reagents and supplies. The contract has a ceiling value of $230,482.66 and a period of performance through November 7, 2025. It is a firm-fixed-price contract with no set-aside designation. Roche Diagnostics is a leading manufacturer and distributor of medical diagnostic technologies, including laboratory instruments, reagents, and test kits. The...
- 36C25023D0030Indefinite Delivery Contract
- 36C25023D0030-36C25024N0279Delivery Order
This is a delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $188,590.32, is for the provision of reagents and supplies. It is a firm-fixed-price contract with a period of performance ending on January 31, 2025. The contract is not set aside for any specific business type. Roche Diagnostics Corporation, a foreign-owned, for-profit organization, has been awarded multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) across various federal agencies, including a $5.5 million BPA with VISN 10 for chemistry laboratory services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($28k) | 6/17/25 | |
| Not listed | Not listed | $216.4k | 1/30/24 |